Li JJ, Zhang WJ, Zeng XH, Zhang QY, et al. Efficacy and Safety of Neoadjuvant TQB2102 in Locally Advanced or Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: A Randomized, Open-Label, Multicenter, Phase II Trial. J Clin Oncol 2025 Nov 25:JCO2501153. doi: 10.1200/JCO-25-01153.
PMID: 41289548